Vanadium One Completes $3.9 Million Funding to Accelerate Development of Its Mont Sorcier Iron Ore-Vanadium Project in Quebec
Funding to support work programs to start Feasibility Study TORONTO, ON / ACCESSWIRE / June…
Funding to support work programs to start Feasibility Study TORONTO, ON / ACCESSWIRE / June…
Financing Enhances Liquidity During El Cubo Refurbishment VANCOUVER, BC / ACCESSWIRE / June 1, 2021…
HOUSTON, TX / ACCESSWIRE / June 1, 2021 / National Energy Services Reunited Corp. (“NESR”…
VANCOUVER, BC / ACCESSWIRE / June 1, 2021 / iMetal Resources, Inc. (TSXV:IMR)(OTC PINK:ADTFF)(FRANKFURT:A7V2) (“iMetal”…
SURREY, BC / ACCESSWIRE / June 1, 2021 / American Manganese Inc.(TSXV:AMY)(OTCQB:AMYZF)(FSE:2AM) (“AMY” or the…
New Kofax TotalAgility Release Accelerates Deployments by Enabling Citizen Developers London, U.K. – June 1,…
Global Telco Consult (GTC) is pleased to announce that it will provide BTS with managed…
Beaverton, US, 01 June 2021: Communication solutions provider, albis-elcon, has become the newest HomeGrid Forum…
June 1, 2021 Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology…
UPPSALA, SWEDEN – LIDDS AB (publ) announced today that Jenni Björnulfson has been appointed new…
PRESS RELEASE NMD Pharma Initiates an Observational Pilot Study Investigating the Effects of Sarcopenia on…
Balixafortide showed a clear anti-viral effect, different from remdesivir, in a 14-day laboratory (CPE) assay…
Press Release Nicox’s Completes Pre-Defined Enrollment of NCX 4251 Mississippi Phase 2b Blepharitis Trial Over…
alfapump® DSR study in Heart Failure patients with persistent congestion GHENT, Belgium, June 01, 2021…
June 1, 2021 Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology…
Sanofi provides update on venglustat clinical program PARIS – JUNE 1, 2021…
Santhera will hold a conference call / webcast today at 16:00 CEST, 15:00 BST, 10:00…
MALVERN, Pa., May 31, 2021 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company…
NEW YORK, May 31, 2021 (GLOBE NEWSWIRE) — Scopus BioPharma Inc. (Nasdaq: “SCPS”) today announced…